AI Drug Discovery Platform IDs Potential COVID-19 Treatments

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical trials immediately. Gero leveraged its AI drug discovery platform to uncover molecules with potential effects on the coronavirus replication.  Some of the drugs that Gero identified have previously been confirmed in many countries for human and veterinary use. A few of the drugs have also been effective against SARS-CoV and SARS CoV-2 viruses, while others have no previous treatment data.